A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

NCT07681089 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Foscenvivint

Sponsor

Kiminori Kimura, MD

Collaborators

[object Object]
[object Object]